Close Menu

NEW YORK – GenMark Diagnostics reported after the close of the market Wednesday that its third quarter revenues rose 32 percent year over year, driven by growth in ePlex molecular diagnostic analyzer placements.

For the three months ended Sept. 30, the firm reported revenues of $20.9 million, up from $15.8 million a year ago, and edging the consensus Wall Street estimate of $20.4 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

NPR reports that researchers have developed chimeric embryos as part of work toward growing human organs in animals for organ transplants.

According to the Washington Post, the Biden Administration is set to make changes to federal restrictions on fetal tissue research.

Texas Monthly looks into the DNA Zoo being collected by Baylor College of Medicine researchers.

In Science this week: approach to isolated trace DNA from archaic humans from sediments, and more.